Hi Shellbell,
I think the data is good, but from my understanding the only new info contained related to specifics on how the version 003 is optimised (which is the version they used in the switching study) vs previous versions (which Penn used in the proof of concept). Little bit on amount of binder required, which is nice from regulatory / cogs too. The way I see it, the data is interesting and backs up SYC's and Rebecca's previous comments about v3, but it is not particularly game changing in itself.
The re-arming and re-targeting data is the important stuff but has been previously announced and followed with several presentations from SYC.
Hopefully more new data to come soon from new studies.. including the cell therapy enhancements which will probably be next.
Cheers
CB
- Forums
- ASX - By Stock
- PTX
- Ann: Prescient to Present at AVID 2022 Meeting
Ann: Prescient to Present at AVID 2022 Meeting, page-13
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $32.21M |
Open | High | Low | Value | Volume |
4.2¢ | 4.2¢ | 4.0¢ | $43.30K | 1.062M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 1110555 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 1110555 | 0.040 |
3 | 243333 | 0.039 |
7 | 431315 | 0.038 |
2 | 109000 | 0.037 |
2 | 575000 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 60000 | 1 |
0.042 | 148294 | 2 |
0.043 | 618217 | 3 |
0.044 | 120777 | 2 |
0.047 | 86129 | 3 |
Last trade - 14.47pm 04/11/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |